Oxidative stress in primary glomerular diseases: a comparative study

被引:0
|
作者
Suchita Markan
Harbir Singh Kohli
Kamal Sud
Monica Ahuja
Tarunveer S. Ahluwalia
Vinay Sakhuja
Madhu Khullar
机构
[1] Post Graduate Institute of Medical Education and Research (PGIMER),Department of Experimental Medicine and Biotechnology
[2] Post Graduate Institute of Medical Education and Research (PGIMER),Department of Nephrology
来源
关键词
Non-proliferative glomerulonephritis; Oxidative stress; Proliferative glomerulonephritis; Reactive oxygen species.;
D O I
暂无
中图分类号
学科分类号
摘要
Objective To evaluate the status of oxidative stress in patients with different primary glomerular diseases (PGD) which have differential predisposition to renal failure. Methods Seventy-three patients with PGD and 50 controls were enrolled in the study. They were sub-grouped into non-proliferative glomerulonephritis (NPGN) and proliferative glomerulonephritis (PGN). Levels of serum malondialdehyde (MDA), reactive nitrogen intermediates (RNI), plasma total homocysteine (tHcy), urine 8-isoprostane (8-IP), RBC thiols, glutathione-S-transferase (GST) and serum superoxide dismutase (SOD) were measured spectrophotometrically. Results PGD patients showed a significant increase in MDA, RNI, tHcy, 8-IP levels (P < 0.05) and decreased SOD, total thiols and protein bound thiol levels as compared to controls (P < 0.05). Significantly higher levels of tHcy, MDA and 8-IP (P < 0.05) and lower SOD enzyme activity (P < 0.05) were observed in PGN group as compared to NPGN and control groups. These changes remained significant even after adjustment was made for creatinine. Conclusions Oxidative stress in PGN is significantly higher than NPGN, indicating higher oxidative stress in these patients, independent of degree of renal dysfunction.
引用
收藏
页码:105 / 110
页数:5
相关论文
共 50 条
  • [21] Mycophenolate mofetil treatment for primary glomerular diseases
    Levin, ML
    KIDNEY INTERNATIONAL, 2002, 62 (04) : 1475 - 1475
  • [22] SERUM IGE IN PRIMARY GLOMERULAR-DISEASES
    LAGRUE, G
    LAURENT, J
    HIRBEC, G
    ANSQUER, JC
    NOIROT, C
    LAURENT, G
    NEBOUT, T
    KESTENBAUM, S
    NEPHRON, 1984, 36 (01): : 5 - 9
  • [23] Primary and Secondary Glomerular Diseases - Update 2017
    Benck, Urs
    Banas, Bernhard
    Birck, Rainer
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (24) : 1832 - 1836
  • [24] Mycophenolate mofetil treatment for primary glomerular diseases
    Choi, MJ
    Eustace, JA
    Gimenez, LF
    Atta, MG
    Scheel, PJ
    Sothinathan, R
    Briggs, WA
    KIDNEY INTERNATIONAL, 2002, 61 (03) : 1098 - 1114
  • [25] A novel approach to study oxidative stress in thyroid diseases: a preliminary study
    Metere, A.
    Chiesa, C.
    Di Cosimo, C.
    Fierro, G.
    Giacomelli, L.
    Pietraforte, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (05) : 646 - 652
  • [26] Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation
    Aguilar, Kevin
    Jakubek, Patrycja
    Zorzano, Antonio
    Wieckowski, Mariusz R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (07)
  • [27] Oxidative stress in human diseases
    Djordjevic, Vidosava B.
    Zvezdanovic, Lilika
    Cosic, Vladan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 158 - 165
  • [28] Oxidative stress, aging, and diseases
    Liguori, Ilaria
    Russo, Gennaro
    Curcio, Francesco
    Bulli, Giulia
    Aran, Luisa
    Della-Morte, David
    Gargiulo, Gaetano
    Testa, Gianluca
    Cacciatore, Francesco
    Bonaduce, Domenico
    Abete, Pasquale
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 757 - 772
  • [29] Oxidative stress, diseases and antioxidants
    Milesi, Marie-Anne
    AGRO FOOD INDUSTRY HI-TECH, 2006, 17 (04): : 6 - 9
  • [30] Oxidative stress in respiratory diseases
    Shelgaonkar, Meena Shriniwas
    Shelgaonkar, Shriniwas Digambar
    Umathe, Sudhir N.
    Munje, Radha Pramod
    FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 : S89 - S90